Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
9
self-reported 2–10 band
Founded
Not recorded
Registry matches
1
ABR
Office countries
1
2 addresses
Funding rounds
2
Post IPO equity · Jun 2025 · US$ 2.1M
Company type
Public Company
self-reported
Legal entity
1 brand → 1 possible registrationMatched by name against ABR, so this is a candidate list, not a confirmed identity. Confidence and match method are shown against every row.
BIO-GENE TECHNOLOGY LIMITED
ABN32071735950
Legal entities
Show as table · Bio-Gene Technology Limited: 1 registry entity
| BIO-GENE TECHNOLOGY LIMITED | ABN 32071735950 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Bio-Gene is an Australian AgTech company that produces a range of patent-protected platforms, QCIDE™ and Flavocide™, targeted at the insecticides market. These technologies have a novel mode of action that offer a new range of effective insecticides that are safe for consumers.
Specialties
All 1 specialty
- insecticides derived from nature and Insecticides
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AULevel 6, 400 Collins Street; Melbourne, Victoria 3000Primary
- AULevel 11, 456 Lonsdale St; Melbourne, Victoria 3000
Grid intelligence Members
Funding
Last round · 5 June 2025US$ 2.1MPost IPO equity
Rounds2
Round typePost IPO equity · secondary transaction
Amount (USD)2,100,000
Stage rank6
Investors named0
Since last round7 mo
Funding
Show as table · 2 funding rounds
| Rounds | 2 |
|---|---|
| Axis | 2024 to 2027 |
| Post IPO equity · 5 Jun 2025 | US$ 2.1M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Bio-Gene Technology Limited?
One Victoria entity on the ABR: BIO-GENE TECHNOLOGY LIMITED (ABN 32 071 735 950), medium confidence.
How many people work at Bio-Gene Technology Limited?
9 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Bio-Gene Technology Limited have offices?
Two addresses on record, Australia only. Primary: Level 6, 400 Collins Street, Melbourne, Victoria 3000.
Has Bio-Gene Technology Limited raised funding?
Two rounds. Latest 5 June 2025: post IPO equity, US$2,100,000.
What does Bio-Gene Technology Limited list as its specialties?
One tag on the brand's own list, among them insecticides derived from nature and Insecticides.
Which companies are listed alongside Bio-Gene Technology Limited?
4 profiles list Bio-Gene Technology Limited as a peer — 56th percentile in Biotechnology Research. It lists ten peers of its own. Fluorescentia lists it back.